SPHK2 and breast carcinoma: We reported that the SK2 inhibitor, (R)-FTY720 methyl ether (ROMe) or siRNA knockdown of SK2 promoted the accumulation of S1P2 in the nucleus of MDA-MB-231 breast cancer cells and this was associated with growth arrest [18].